A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization

Intervirology

Volumn 48, Issue 1, 2005, Pages 46-51

  Chung, Young Hwa ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Angiography; Hepatocellular carcinoma; Transcatheter arterial chemoembolization

Indexed keywords

GELFOAM; IODINATED POPPYSEED OIL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER REGRESSION; CATHETER; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL;

ADULT; AGED; ALPHA-FETOPROTEINS; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17244382448     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082094     Document Type: Article

References (21)

1. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K: Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986;99:694-701.
2. Gozzetti G, Mazziotti A, Cavallari A, Bellusci R, Bolondi L, Grigioni W, et al: Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis. Surg Gynecol Obstet 1988;166:503-510.
3. Wall WJ, Marotta PJ: Surgery and transplantation for hepatocellular cancer. Liver Transplant 2000;6:S16-S22.
4. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K: Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 1991;68:2150-2154.
5. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan: Clinicopathological features and results of surgical treatment. Ann Surg 1990;211:277-287.
6. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan Six report. Cancer 1987;60:1400-1411.
7. Chung YH, Yang SK, Lee JS, Min YI, Lee MG, Sung KB, et al: Effect of cisplatin and adriamycin in the chemoembolization therapy for patients with unresectable hepatocellular carcinoma. Kor J Gastroenterol 1992;24:790-797.
8. Lin DY, Liaw YF, Lee TY, Lai CM: Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Gasroenterology 1988;94:453-456.
9. Takayasu K, Moriyama N, Muramatsu Y, Suzuki M, Yamada T, Kishi K, et al: Hepatic arterial embolization for hepatocellular carcinoma: comparison of CT scans and resected specimens. Radiology 1984;150:661-665.
10. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, et al: Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors. Hepatology 1994;19:1115-1123.
11. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, et al: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108:768-775.
12. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Kawano N, et al: Surgical resection for small hepatocellular carcinoma. Surgery 1996;119:40-45.
13. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, et al: Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
14. Bronowicki JP, Boudjema K, Chone L, Nisand G, Bazin C, Pflumio F, et al: Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 1996;24:293-300.
15. Chen DS, Sung JL: Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977;40:779-783.
16. Castellano L, Calandra M, Del Vecchio Blanco C, de Sio I: Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients. J Hepatol 1997;27:862-870.
17. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, Fujita M, Ishiguro S: Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intra-arterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989;97:965-971.
18. Takayasu K, Suzuki M, Uesaka K, Muramatsu Y, Moriyama N, Yoshida T, et al: Hepatic arterial embolization for inoperable hepatocellular carcinoma: Progress and risk factors. Cancer Chemother Pharmacol 1989;23:S123-S125.
19. Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H: Diagnosis and treatment for recurrent hepatocelluar carcinoma. Jpn J Cancer Chemother 1998;25:327-332.
20. Chung Y-H, Song IH, Song B-C, Lee GC, Koh MS, Yoon H-K, et al: Combined therapy consisting of intra-arterial cisplatin infusion and systemic interferon-a for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000;88:1986-1991.
21. Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Hirohashi S, Nishimura Y, et al: Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: Follow-up CT and therapeutic results. Cancer Chemother Pharmacol 1994;33:S60-S68.